COVID-19. Use this code when COVID-19 has been confirmed by laboratory testing irrespective of severity of clinical signs or symptoms. Use additional code, if desired, to identify pneumonia or other manifestations.
Conditions
Interventions
Intervention 1: Intervention group:. Intervention 2: Control group:.
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patient admitted to covid-19 wards of Sabzevar Vasei Hospital, Positive PCR test result Willingness to cooperate (written consent) Phase 2 of Covid disease -19 (moderate or severe)
Exclusion criteria
Exclusion criteria: Cigarette and drug addiction History of drug use or methadone therapy Liver failure Breastfeeding and pregnant women Pulmonary insufficiency Kidney failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of respiration is measured quantitatively by improving the percentage of peripheral blood oxygen, which is measured by pulse oximetry, and qualitatively by increasing the score of the vas and borg questionnaires. Timepoint: Daily at a specific time (12 noon) for up to 4 days. Method of measurement: Percentage of peripheral blood oxygen with pulse oximetry. Respiratory quality with vas and borg questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Ghardashi
Sabzevar University of Medical Sciences
Outcome results
None listed